ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 66 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $77,000 | +13.2% | 20,000 | 0.0% | 0.01% | +9.1% |
Q2 2018 | $68,000 | -46.0% | 20,000 | -66.7% | 0.01% | -50.0% |
Q1 2018 | $126,000 | -11.3% | 60,000 | -14.3% | 0.02% | -12.0% |
Q4 2017 | $142,000 | -56.3% | 70,000 | -0.9% | 0.02% | -57.6% |
Q3 2017 | $325,000 | +113.8% | 70,660 | 0.0% | 0.06% | +103.4% |
Q2 2017 | $152,000 | -40.2% | 70,660 | -12.4% | 0.03% | -42.0% |
Q1 2017 | $254,000 | +21.0% | 80,660 | 0.0% | 0.05% | +19.0% |
Q4 2016 | $210,000 | -33.1% | 80,660 | 0.0% | 0.04% | -34.4% |
Q3 2016 | $314,000 | +44.7% | 80,660 | 0.0% | 0.06% | +39.1% |
Q2 2016 | $217,000 | -12.5% | 80,660 | 0.0% | 0.05% | -16.4% |
Q1 2016 | $248,000 | -8.8% | 80,660 | +14.2% | 0.06% | -17.9% |
Q4 2015 | $272,000 | +25.9% | 70,660 | 0.0% | 0.07% | +15.5% |
Q3 2015 | $216,000 | -28.0% | 70,660 | 0.0% | 0.06% | -24.7% |
Q2 2015 | $300,000 | +9.9% | 70,660 | 0.0% | 0.08% | +11.6% |
Q1 2015 | $273,000 | -70.1% | 70,660 | -47.9% | 0.07% | -71.8% |
Q4 2014 | $913,000 | – | 135,660 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |